One-step preparation of poly(ϵ-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles for plasmid DNA delivery

In this article, a kind of biodegradable poly(ϵ-caprolactone)-Poly(ethylene glycol)-poly(ϵ-caprolactone) (PCL-PEG-PCL, PCEC) copolymer was synthesized by ring-opening polymerization method. The PCEC nanoparticles were prepared at one-step by modified emulsion solvent evaporation method using CTAB as stabilizer. With increase in PCEC concentration, the particle size increased obviously, but zeta potential only increased slightly. The obtained cationic PCEC nanoparticle was employed to condense and adsorb DNA onto its surface. Plasmid GFP (pGFP) was used as model plasmid to evaluate the loading capacity of cationic PCEC nanoparticles in this work. The DNA/nanoparticles weight ratio at 1:16 induced almost neutral zeta potential of DNA-nanoparticles complex. At this time, the size of complex became abnormally large which implied aggregates formed. So DNA-nanoparticles weight ratio should be chosen carefully. The cationic PCEC nanoparticles had the capacity of condensing plasmid DNA into complex when the DNA/nanoparticles weight ratio was lower than 1:8, which was evidenced by gel retardation assay. In vitro release behavior of DNA/nanoparticle complexes was also studied here. The obtained cationic PCEC nanoparticles might have great potential application in DNA delivery. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008

[1]  V. Labhasetwar,et al.  Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. , 2002, International journal of pharmaceutics.

[2]  Sung Wan Kim,et al.  Current status of polymeric gene delivery systems. , 2006, Advanced drug delivery reviews.

[3]  R. Langer,et al.  Designing materials for biology and medicine , 2004, Nature.

[4]  J. Roth,et al.  Gene therapy for cancer: what have we done and where are we going? , 1997, Journal of the National Cancer Institute.

[5]  O'donnell,et al.  Preparation of microspheres by the solvent evaporation technique. , 1997, Advanced drug delivery reviews.

[6]  D. McDonald,et al.  Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles. , 2003, Cellular immunology.

[7]  R. Langer,et al.  Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy. , 1997, Biomaterials.

[8]  Jun Li,et al.  Cationic star polymers consisting of alpha-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors. , 2007, Biomaterials.

[9]  Hu Yang,et al.  Penicillin V-conjugated PEG-PAMAM star polymers , 2003, Journal of biomaterials science. Polymer edition.

[10]  G. Ott,et al.  The Preparation, Characterization, and Evaluation of Cationic Microparticles for DNA Vaccine Delivery , 2001, Pharmaceutical Research.

[11]  Jun Li,et al.  Cationic Supramolecules Composed of Multiple Oligoethylenimine‐Grafted β‐Cyclodextrins Threaded on a Polymer Chain for Efficient Gene Delivery , 2006 .

[12]  Xuesi Chen,et al.  Synthesis and characterization of PCL/PEG/PCL triblock copolymers by using calcium catalyst , 2003 .

[13]  Soriano,et al.  The Adsorption of Poly(vinyl alcohol) to Biodegradable Microparticles Studied by X-Ray Photoelectron Spectroscopy (XPS) , 1997, Journal of colloid and interface science.

[14]  J. Wixon,et al.  Gene therapy clinical trials worldwide 1989–2004—an overview , 2004, The journal of gene medicine.

[15]  M. Blanco-Prieto,et al.  Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. , 1997, Advanced drug delivery reviews.

[16]  Kazunori Kataoka,et al.  PEGylated Nanoparticles for Biological and Pharmaceutical Applications , 2003 .

[17]  D. Putnam,et al.  PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. , 1999, Journal of pharmaceutical sciences.

[18]  Manmohan J. Singh,et al.  The Effect of CTAB Concentration in Cationic PLG Microparticles on DNA Adsorption and in Vivo Performance , 2003, Pharmaceutical Research.

[19]  Woo-Sik Kim,et al.  Effects of charge density and particle size of poly(styrene/(dimethylamino)ethyl methacrylate) nanoparticle for gene delivery in 293 cells , 2002 .

[20]  L. Bonetta.  Leukemia case triggers tighter gene-therapy controls , 2002, Nature Medicine.

[21]  Fu Qiu,et al.  Lecithin-based cationic nanoparticles as a potential DNA delivery system. , 2006, International journal of pharmaceutics.

[22]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[23]  R. Mumper,et al.  Topical immunization using nanoengineered genetic vaccines. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[24]  S. W. Kim,et al.  Development of biomaterials for gene therapy. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  Luigi Naldini,et al.  Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics , 2001, Nature Medicine.

[26]  Ann-Christine Albertsson,et al.  Degradable polymer microspheres for controlled drug delivery , 2002 .

[27]  Manmohan J. Singh,et al.  Cationic microparticles: A potent delivery system for DNA vaccines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  I. Stratford,et al.  Targeting gene therapy to cancer: a review. , 1997, Oncology research.